Cardiovascular changes in chronic hemodialysis patients  by Ikram, Hamid et al.
Kidney International, Vol. 24 (1983), pp. 371—376
Cardiovascular changes in chronic hemodialysis patients
HAMID IKRAM, KELVIN L. LYNN, Ross R. BAILEY, and PETER J. LITTLE
Department of Cardiology, The Princess Margaret Hospital and Department of Nephrology, Christchurch Hospital,
Christchurch, New Zealand
Cardiovascular changes in chronic hemodialysis patients. Coronary
angiography and left ventricular (LV) hemodynamic studies were
performed after dialysis in 32 home dialysis patients (20 men) aged 49.8
8.0 years. They had been on hemodialysis for 1 to 47 months and
were being considered for renal transplantation. The controls were 11
normotensive patients (6 men) aged 46. I 11 years without coronary
artery disease (CAD). Ten (31%) patients had significant CAD (5 single
vessel, 3 double vessel, 2 triple vessel). Cardiac index (4.57 1.3
I/minim2), LV mass (140 43 g/m2), mean aortic pressure (103 20mm
Hg), and LV stroke work index (72 30 g mIm2) were significantly
elevated while stroke index, heart rate, LV ejection fraction, maximum
dP/dT, LV end-diastolic volume and LV end-diastolic pressure were
normal. The hemodynamic changes did not correlate with the time on
maintenance dialysis nor with the duration of treatment for hyperten-
sion. Patients with CAD had higher LV mass and mean aortic pressure
than those without CAD. The cardiac changes are thought to result
from a combination of pressure and volume loads and anemia.
Modifications cardiovasculaires chez des malades en hémodialyse
chronique. Des etudes avec angiographie coronaire et hemodynamique
ventriculaire gauche (LV) ont été effectuées après Ia dialyse chez 32
malades en dialyse a domicile (20 hommes) ages de 49.8 8.0 ans. Ils
Ctaient en hCmodialyse depuis I a 47 mois, et étaient en attente de
transplantation rénale. Les contrôles étaient II sujets normo-tendus (6
hommes) âgés de 46.1 11 ans sans maladie artCrielle coronaire (CAD).
Dix (31%) malades avaient une CAD significative (5 sur un seul
vaisseau, 3 sur deux vaisseaux, 2 sur trois vaisseaux). L'index cardi-
aque 4.57 1.3 I/min/m2), Ia masse du LV (140 43 g/m2), Ia pression
aortique moyenne (103 20 mm Hg), et l'index de travail d'éjection du
LV (72 30 g mIm2) Ctaient significativement élevës, tandis que
l'index d'éjection, Ic rythme cardiaque, Ia fraction d'éjection du LV, le
dP/dT maximum, Ic volume tClddiastolique du LV, et Ia pression télédi-
astolique du LV étaient normaux. Les modifications hemodynamiques
n'étaient pas corrélées avec Ia durée d'hémodialyse, ni avec Ia durée du
traitement hypotenseur. Les malades avec CAD avaient une masse de
LV et une pression aortique moyenne plus Clevées que ceux sans CAD.
Ces modifications cardiaques rCsultent probablement d'une combinai-
son d'une surcharge en pression et en volume et de l'anémie.
The effects of chronic renal failure, and hemodialysis on the
heart remain controversial. Coronary artery disease (CAD) is
said to be common in patients with endstage renal failure [1—4]
and is a major cause of death [1, 2]. There is, however, a
paucity of angiographic studies in hemodialysis patients and
uncertainty as to whether hemodialysis is associated with
accelerated atherosclerosis [2—7].
Anemia, fluid and electrolyte imbalance, myocardial calcifi-
cation, "uremic toxins," and episodes of extracorporeal circu-
lation may adversely affect myocardial function in hemodialysis
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patients. Nevertheless, some authors have found cardiac func-
tion to be normal in uremic patients [8, 9] while others have
found abnormal cardiac function and ascribed this to either a
specific uremic cardiomyopathy [10—15] or to pressure-volume
overload and anemia [16]. Clinical evaluation of cardiac compli-
cations may be fallacious because circulatory congestion simu-
lating cardiac failure may occur despite normal cardiac pres-
sures [17].
There are few comprehensive studies of left ventricular
function in dialysis patients, as invasive studies are usually
avoided. The results of the noninvasive studies are difficult to
evaluate because the existence and effects of complicating CAD
have not been established or have been ignored. Until recently,
the published catheter studies [13, 14, 16, 18] provided little
information about cardiac function in dialysis patients because
they were based on small numbers of patients with complica-
tions. Other investigators [19—22] have used such indices of
cardiac function as cardiac output, blood pressure, and heart
rate.
Several unexpected deaths that occurred from myocardial
infarction following recent cadaveric renal transplantation in
patients without obvious cardiovascular disease prompted us
beginning in 1975 to undertake invasive cardiac studies in all
hemodialysis patients over the age of 40 years being considered
for renal transplantation and in younger patients with symptoms
suggestive of ischemic heart disease. In these patients coronary
angiography and studies of left ventricular function were under-
taken to:
(1) determine the incidence of CAD and some of the factors
affecting it,
(2) evaluate left ventricular function and the factors influenc-
ing it,
(3) evaluate the usefulness of this information in identifying
which potential renal transplant recipients with CAD were at
risk of acute myocardial infarction following transplantation,
and
(4) evaluate the effects on survival of the presence or ab-
sence of CAD in these patients.
Subjects. Thirty-two patients (20 men), with a mean age of
49.8 8.0 years, were studied. They were then followed for 27
19 months. The relevant clinical data are shown in Table I.
All patients were in training for, or on, home hemodialysis and
dialyzed for 9 to 12 hours three times each week. The patients
had been on dialysis for 1 to 47 months. At the beginning of the
study all patients were using multipoint Kiil dialysers (1.0 m2)
but a change was later made to Gambro plate dialysers (1.0 m2).
At all times a Drake-Willock proportioning system and an
acetate-containing dialysate (40 mM) were used. The majority of
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I M 48 MON
2 F 32 LN
3 M 43 RN
4 M 59 ON
5 M 49 FGS
6 F 52 FGS
7 M 59 FGS
8 M 41 PKD
9 M 48 DN
10 M 49 PKD
11 M 53 AN
12 F 38 AN
13 M 54 IN
14 M 56 ON
15 M 40 DN
16 F 57 PKD
17 M
IS F
19 F
51 PKD
54 Gout56 IN
20 M 42 BP
21 F SI CD
22 M 65 ON
23 M 44 ON
24 F 62 Unknown
25 M 59 BP
26 F SI PKD
27 F 35 GN
28 F 41 PKD
29 F 54 AN
30 M 47 PKD
31 M 45 MGN
32 M 57 ON
8.2
6.1
10.2
6.5
10.6
6.5
8.1
10.2
7.5
7.0
9.5
7.8
7.2 9 0.54
6.5 6 0.51
9.9 3 0.77
7.6 1 0.57
11.6 1 0.59
7.5 11 0.53
6.4 1 0.49
6.0 2 0.48
8.2 2 0.54
13.8 9 0.53
9.4 39 0.56
8.4 40 0.52
5.2 5 0.48
7.3 7 0.45
8.0 3 0.51
7.7 I 0.41
8.0 5 0.58
9.8 3 0.57
8.6 l 0.55
10.2 30 0.47
8.3 1.8 9.0 13.4 0.53 0.08
Digoxin 0.0625 mg daily
Debrisoquine 15 mg q
12 hr
Prazosin 2 mg q 8 hr
Digoxin 0.0625 mg daily
Labetalol 600 mg q 12
hr
Digoxin 0.0625 mg daily
Timolol 10 mg q 12 hr
Alpha methyldopa 125
mg daily
Anginine
Timolol 5 mg daily
Timolol 10 mg q 12 hr
Methyldopa 250 mg q 8
hr
Tirnolol 5 mg daily
Digoxin 0.0625 mg daily
Verapamil 80 mg q 8 hr
LCA, RCA
LAD
LAD
LAD
LAD, LCA. RCA
RCA
LAD, LCA, RCA
LAD, LCA
— 7
— 9
— 55
— 43
— 42
+ 23
— 56
— 5
— 3
— 3
— 55
— 22
— 8
— 12
— 36
— 50
— SI
+ 17
+ 20
— 18
+ 32
+ 60
— 55
— 18
— 12
— 12
— 41
+ 12
+ 6
— 17
+ 15
29
patients had an arteriovenous fistula. There were no dietary
restrictions and all patients took water-soluble vitamin and iron
supplements. All patients taking digoxin did so because of a
history of atrial fibrillation. All patients were in sinus rhythm at
the time of study and none had overt cardiac failure.
The control group consisted of 11 normotensive patients (six
men), with a mean age of 46.1 11 years, who were investigat-
ed because of chest pain. They had no CAD on selective
coronary angiography and normal cardiac and renal function.
Methods
Informed consent was obtained from each patient prior to the
invasive studies. Cardiac studies were peformed 5 to 18 hr after
a hemodialysis treatment. A chest radiograph and electrocar-
diogram were taken immediately prior to the study, and blood
was taken for fasting lipid concentrations and hematocrit esti-
mation. All patients were fasting and given diazepam (10 mg)
intramuscularly and atropine (10 mg) subcutaneously 1 hr
before the study. Coronary angiography was performed using
the femoral artery approach in 29 patients and the brachial
artery approach in three. There were no deaths. One patient
developed a groin hematoma. The coronary angiograms were
reported independently by two observers. A 50% diameter
reduction (that is, equivalent to 75% cross-sectional reduction)
in the caliber of a major coronary artery was regarded as
significant CAD [23]. Left ventricular (LV) angiography was
performed in the 30° right anterior oblique projection via an 8
French 'Pigtail' catheter using a slow injection of 50 ml of 76%
Table 1. Clinical data of 32 hemodialysis patients undergoing coronary angiography and study of left ventricular function
Age Renal Hb
Duration
of dialysis
Cardio-
thoracic Cardiovascular
Coronary
angiography
Symptoms
suggestive
Duration of
follow-up
Patients Sex years lesion° gidi months ratio medication findingsh of CAD months
0.45 —
0.66 Digoxin 0.0625 3 x wk
Metoprolol 100 mg daily
47
17
2
1.5
34
0.76
0.51
0.50
0.56
0.46
0.41
0.49
0.42
0.50
0.55
LAD, LCA
LAD
Mean SD 49.8 8.0
° Abbreviations in this column are: PKD, polycystic kidney disease; IN, interstitial nephritis; BP, hypertensive nephrosclerosis; CD, calculous
disease; ON, unspecified glomerulonephritis; AN, analgesic nephropathy; MON. membranous glomerulonephritis; DN, diabetic nephropathy;
FOS, focal glomerulosclerosis; LN, lupus nephritis.
Abbreviations used in this column are: LAD, left anterior descending coronary artery; LCA, left circumflex coronary artery; RCA, right
coronary artery.
26.4 18
Cardiovascular changes and dialysis 373
sodium and meglumine diatrizoate (Urografin, Schering AG,
Berlin, West Germany). Cardiac output was measured in tripli-
cate by the dye-dilution method using a cuvette densitometer
(Model X-301, Waters Instruments Inc., Pasadena, California)
calibrated by the dynamic calibration method [24]. LV pressure
was measured via 8 French 'Pigtail' catheters connected to
strain gauge transducers (Bell and Howell Instruments Divi-
sion, Rochester, Minnesota). The zero reference was the ster-
nal angle. The LV pressure signal was recorded on paper as
well and fed into a resistance-capacitance differentiating circuit.
The rate of change of LV pressure was recorded continuously.
The various indices of LV function detailed below were derived
from digitized pressure and angiography data using standard
programs. The hemoglobin concentration was measured on a
Coulter counter and the fasting cholesterol and triglyceride
concentration by standard enzymatic methods.
Definitions and data analysis. Cardiomegaly was defined as a
cardiothoracic ratio greater than 0.5. The electrocardiogram
was analyzed by an independent observer for evidence of LV
hypertrophy and changes consistent with myocardial ischemia
using standard criteria [251. For the purposes of this study
smoking was defined as the consumption of at least 10 ciga-
rettes/day for at least 10 years.
Ventricular volumes were calculated from single plane right
anterior oblique LV cine angiograms using a special purpose
calculator [26]. End-diastolic and end-systolic LV volumes
were calculated and normalized for body surface area. LV
ejection fraction was calculated from the formula:
Ejection fraction =
End-diastolic volume — End-systolic volume
xIOO%End-diastolic volume
LV mass was calculated from the single plane angiogram by the
method of Kennedy et al [27].
The left ventricular stroke work index (LVSWI) was calculated
using the formula [28]:
LVSWI = Stroke index x (Mean aortic — LV end-diastolic
pressure) x 0.0136
Statistical methods. Apart from Fisher's exact probability test,
statistical analyses were carried out using programs from the
BMDP Statistical Package. The results are expressed as mean
SD.
Results
Coronary artery disease. The coronary angiographic findings
are summarized in Table 1. No patient had significant left main
coronary artery stenosis, and there were no abnormalities of
LV segmental wall motion. The finding of CAD did not corre-
late with the time on maintenance dialysis (P > 0.5), age (P>
0.5), plasma cholesterol concentration (P = 0.18), plasma
triglyceride concentration (P = 0.20) nor any of the categorical
indicators (Table 2). Patients with CAD had received antihyper-
tensive treatment for a shorter time before dialysis than those
without CAD (50 31 vs. 89 84 months, P = 0.07). But there
was no difference between the blood pressure before the first
dialysis in patients with CAD (systolic 170 27 mm Hg;
diastolic 95 13 mm Hg) and those without CAD (systolic 161
23 mm Hg, diastolic 96 8 mm Hg).
Left ventricular function. The hemodynamic findings are
summarized in Table 3. The cardiac index, LV mass, LVSWI,
Sex 0.55 7/20 (male) 3/12 (female)
Symptoms of CAD 0.19 4/8 6/24
Smoking 0.47 5/13 5/19
Family history CAD 0.21 5/lI 5/21
X-ray LVII' 0.21 4/18 6/14
ECG LVH5 0.56 4/11 5/19d
ECG M1 0.37 5/13 4/17d
Age,years 46.1 11 NS 49.8 8
Surface area, m2 1.77 0.18 NS 1.75 0.18
Cardiac index,
I/mm/rn2 3.31 0.9 <0.01 4.57 1.3
Stroke index, mi/rn2 48.4 16 NS 58.4 17
Heart rate, bt/min 74.9 II NS 80.2 12
LV end-diastolic
volume, mI/rn2 88.6 21 NS 101.7 29
LV mass, g/m2 97.1 31 0.005 140 43
Ejection fraction, % 66.2 II NS 70.9 12
Mean aortic pressure,
mm Hg 93.1 8.7 0.024 103 20
Max LV dP/dT, mm
Hg/sec 1909 417 NS 2133 624
LV end-diastolic
pressure, mm Hg 10.4 4 NS 12.2 9
LVSWI, g rn/rn2 53 17 <0.02 72 30
and mean aortic pressure were significantly increased but the
LV ejection fraction was normal. There was a positive linear
correlation between LV ejection fraction and the duration of
dialysis (r = 0.39; 0.02 <P < 0.05) but no such relationship for
any of the other hemodynamic variables. There was no relation-
ship between hemoglobin concentration and cardiac index.
There tended to be a positive correlation between LV mass and
mean aortic pressure and the presence of CAD (P = 0.09 and P
= 0.06, respectively). Discriminative analyses of all the hemo-
dynamic variables, with or without inclusion of the 'noninva-
sive' variables, was no better than mean aortic pressure in
distinguishing between patients with and without CAD. The
duration of treatment for hypertension before dialysis was
unrelated to any of the hemodynamic variables.
Outcome. All patients with CAD were removed from the
transplant waiting list. The two patients with triple vessel
disease underwent successful coronary artery bypass surgery.
Eighteen of the 22 patients free of CAD, including two with
symptoms suggestive of ischemic heart disease (patients 21 and
22, Table 1), received a cadaveric renal transplant (Table 4). No
patient in our study receiving a renal transplant has died from a
myocardial infarction to date. There was no significant differ-
ence in the cumulative survival of patients with CAD compared
Table 2. Relationship between the presence of coronary artery disease
(CAD) and categorical indicators
Variable P from x2 P (CAD/+ve) P (CAD/—ye)
The variable is left ventricular hypertrophy on a chest radiograph.
b The variable is left ventricular hypertrophy on an electrocardio-
gram.
The variable is myocardial ischemia on an electrocardiogram.
Two patients did not have an electrocardiogram.
Table 3. Left ventricular (LV) function in hemodialysis patients and
normal subjects
Normal subjects
N= 11
Hemodialysis
patients
P N=32
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to those without CAD (Mantel's generalized Savage statistic, P
= 0.15; Breslow's generalized Wilcoxon statistic, P = 0.37).
Among the 11 patients (34%) who died during the follow-up
period of 26.4 18 months myocardial infarction was more
common in those with CAD (P = 0.061).
Discussion
Since 1975 we have undertaken invasive cardiac studies in 32
hemodialysis patients with a mean age of approximately 50
years, most of whom had been on dialysis for 1 year or less.
These patients were assessed for renal transplantation. There
were no deaths or significant morbidity associated with the
procedure. The patients were mainly free of symptoms sugges-
tive of CAD and had been followed for a mean of 2 years.
During this time a total of 90 patients, ranging in age from 6 to
73 years, entered our dialysis/transplantation program, and 66
first cadaver transplants were undertaken.
In the study group we found an incidence of CAD of 31%.
This finding is similar to those of Braun et al [4] who found 39%
of 70 nondiabetic dialysis patients to have significant CAD and
Rostand et a! [6] who found seven patients with CAD in 33
(2 1%) postmortem examinations performed on hemodialysis
patients who died after being on dialysis for 2 to 68 months.
CAD was equally common in men and women in contrast to the
findings in subjects with normal renal function [29] which
confirms an earlier observation [6]. Ibels et al [30] have
attributed deaths due to fatal occlusive arterial disease in the
early post-transplantation period to the stress of surgery and
immunosuppressive therapy in those with pre-existing arterial
disease. Braun et al [4] suggested that elective coronary angiog-
raphy may be helpful in identifying these patients at risk. This is
also our impression although we have studied a relatively small
number of patients with a short follow-up period.
Of the 24 patients without symptoms suggestive of CAD that
we have studied six had occult CAD. None of the 18 patients
free of significant CAD who received a cadaveric renal trans-
plant have suffered a myocardial infarction while three of the
ten patients with significant CAD continuing on hemodialysis
have done so (Table 4). On the other hand, patients with
symptoms suggestive of ischemic heart disease, but normal
coronary arteries, appear to have a good cardiac prognosis.
Whether the patients with CAD who suffered a myocardial
infarction on hemodialysis would have done so following trans-
plantation is conjectural. There is, however, evidence suggest-
ing that the incidence of myocardial infarction is higher in
dialysis patients than transplant recipients [1, 2, 31]. Neverthe-
less, in the only other angiographic study, myocardial infarction
occurred in hemodialysis patients and transplant recipients with
CAD with similar frequency [4].
None of the clinical, historical, or hemodynamic data ob-
tained in the present study was sufficient to identify those of our
patients with CAD. Thus, when evaluating the presence or
absence of CAD in patients on chronic hemodialysis, coronary
angiography appears to be necessary. The lack of relationship
between blood pressure and CAD is surprising in view of
contrasting reports [29]. Hypertension has been correlated in
hemodialysis patients with clinical occlusive arterial disease [3]
and atherosclerosis of the iliac vasculature as assessed at the
time of renal transplantation [33]. Rostand, Kirk, and Rutsky
[32] have shown a significant relationship between the diastolic
Table 4. Outcome, mode of treatment, and coronary artery disease
(CAD)
Outcome
Dead
Myocardial Other
Mode of treatment (N) Alive infarction causes
CADa Hemodialysis (10) 5 3 2
No CAD Transplant (18)
Hemodialysis (4)
14
2
0
0
4
2
No patient with CAD was transplanted.
blood pressure immediately before the start of maintenance
hemodialysis and clinical ischemic heart disease. However, this
association is by no means unequivocal as they were unable to
show any correlation of the initial systolic blood pressure or the
average blood pressure while on maintenance hemodialysis
with CAD. We were unable to confirm the association between
the initial diastolic blood pressure and CAD in our study group.
We did not find any relationship between CAD and the duration
of treatment for hypertension before starting hemodialysis.
The mean aortic blood pressure measurement in our study
was obtained after a dialysis and therefore is likely to represent
the lowest blood pressure for our patients. It is conceivable that
at other times the blood pressure would be higher and that, if
larger numbers of patients were studied, a similar positive
relationship between hypertension and CAD, as has been
suggested by other investigators [3, 32], would have been
found. Certainly, in our study the mean aortic blood pressure
was found to be the best determinant of the presence or absence
of CAD.
The hemodynamic data reported for our control group are
similar to those obtained by other investigators [27, 34]. The
most fully explored aspect of cardiac pump function in uremia
has been cardiac output. This study confirms previous reports
that the cardiac index is significantly elevated (Table 5). In
contrast, the cardiac output appears to be normal in uremic
patients not on dialysis who are free of fluid overload [8, 35].
Some investigators [19, 21] have found an increased stroke
index in hemodialysis patients while others have found it to be
normal [16, 22] (Table 5). Because the occlusion of the fistula or
shunt [16, 36] or correction of the anemia [21] are said to
normalize the cardiac output they are probably the two main
factors involved. Nevertheless, in our patients we could show
no relationship between the cardiac output and the hemoglobin
concentration. It seems most likely that the increase in cardiac
index results from increases in both stroke index and heart rate.
The LV systolic ejection fraction is the most commonly used
index of LV systolic function. It has been shown to correlate
closely with medical prognosis and the outcome of cardiac
surgery in those with [4] and without [37] renal failure. Our
findings indicate that LV ejection fraction is normal in hemodi-
alysis patients when measured angiographically and agrees with
the findings of Braun et al (4] which is the only published
angiographic study to our knowledge in which coronary anato-
my has been established. Moreover, there was no evidence that
the LV ejection fraction fell in patients who had been on
dialysis for prolonged periods of time.
There was a significant increase in LV mass which was,
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Table 5. Left ventricular (LV) function in hemodialysis patients studied by invasive methods
Reference
No.
studied
Cardiac index
liter/minim2
Stroke index
mi/rn2
Ejection
fraction
%
Mean aortic
pressure
mm Hg
Max LV dP/dT
mm Hg/sec
LV end-diastolic
pressure
mm Hg
del Greco et al [20] 13 4.32 — — — — —
Mostert et al [19] 21 4.19 48.6 — 118 — —
Neffet al [21] 40 4.76 56 — 112 — —
Kim et al [22] 75 4.4 50 — — — —
Scheeretal [13]b 7 4.05 — 32 — 1117 22.7
Capelli and Kasparian [16] 9 4.3 52.7 — 123 1369 17
Drueke et a! [l8]' 15 3.34 — 50 102 — 16.8
Present study 32 4.57 1.3 58.4 17 70.9 12 103 20 2133 624 12.2 9
Values represent mean results.
b Patients reported are those with congestive cardiomyopathy.
surprisingly, unrelated to the time on maintenance hemodialysis
and hypertension although it is conceded that our study does
not exclude such relationships. Nevertheless, it is of interest
that Rambausek et a! [38] showed in a uremic rat model that
increase in heart weight could be dissociated from hypertension
and was associated with an increased cyclic AMP and calcium
content of the heart. There is no comparable data on hemodialy-
sis patients not suffering from cardiac complications. However,
hemodialysis patients with congestive cardiomyopathy do have
increased LV mass [16, 18]. The increased LV mass is consist-
ent with the increased LVSWI (Table 3) that we and other
investigators [161 have shown. This increase in LVSWI was not
affected by the time on maintenance dialysis.
The peak LV dPidT is an index of myocardial contractility
which is affected by preload and afterload variation. Scheer et
a! [13] found depressed LV dP/dT in hemodialysis patients with
low LV ejection fraction and cardiomegaly. In patients without
cardiac complications, as in the present study, and those of
Capelli and Kasparian [16], the LV dP/dT was normal (Table 5).
The lack of a significant increase in LV dP/dT in the presence of
increased LVSWI suggests depression of myocardial contractil-
ity as the increase in preload and afterload associated with
dialysis would be expected to result in an increase in LV dP/dT.
Measurements of LV diastolic function revealed no signifi-
cant differences from normal. There are no other angiographic
data on LV diastolic function in uncomplicated patients. The
mean value for LV end-diastolic pressure of 12.2 mm Hg is
lower than that reported in dialysis patients with complications
[13, 16, 181 (Table 5). The LV end-diastolic volume was
elevated but not significantly above normal.
This study suggests that the continuing controversy over the
existence of a uremic cardiomyopathy may be largely a seman-
tic one. Without the assistance of invasive studies the clinical
features that lead to a diagnosis of heart failure are extremely
difficult to distinguish from those of fluid overload. Other
investigators have studied highly selected samples of patients
with overt cardiac problems. We believe our study group to be
more representative of well dialyzed patients. Nevertheless,
our data do demonstrate that patients, without overt cardiac
complications studied under optimal control of uremia, within 1
to 2 years of starting hemodialysis, exhibit significant cardio-
vascular abnormalities, namely cardiac hypertrophy, dilatation,
and possibly depression of contractility. These changes did not
correlate with the presence or absence of CAD, and we believe
that they result from a combination of hemodynamic loads
rather than a unique pathologic process.
In summary, coronary angiography is a safe and effective
means of identifying CAD in potential renal transplant recipi-
ents. Increased LV mass and mean aortic pressure appears to
be commoner in patients with CAD. LV function is well
preserved in hemodialysis patients, but they have a significantly
greater cardiac output, LV mass, and LVSWI when compared
to normal subjects. None of these increases could be correlated
with the duration of maintenance dialysis, mean aortic pressure
at the time of study, or the duration of treatment for hyperten-
sion. These changes are thought to result from a combination of
pressure and volume loads and anemia.
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